VISMODEGIB vs VONOPRAZAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VISMODEGIB vs VONOPRAZAN: Safety Overview
| Metric | VISMODEGIB | VONOPRAZAN |
|---|---|---|
| Total FAERS Reports | 8,135 | 2,019 |
| Deaths Reported | 864 | 73 |
| Death Rate | 10.6% | 3.6% |
| Hospitalizations | 974 | 342 |
| Average Patient Age | 69.6 yrs | 63.6 yrs |
| % Female Patients | 39.3% | 65.3% |
| FDA Approval Date | Jan 30, 2012 | Nov 1, 2023 |
| Manufacturer | Genentech, Inc. | Phathom Pharmaceuticals Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |